Metody medycyny nuklearnej w nieinwazyjnej diagnostyce kardiologicznej Artykuł przeglądowy

##plugins.themes.bootstrap3.article.main##

Maria Różańska
Olga Możeńska
Tadeusz Budlewski
Dariusz A. Kosior

Abstrakt

Medycyna nuklearna to wszelka działalność diagnostyczna i terapeutyczna z użyciem radiofarmaceutyków. Podstawowe metody to tomografia emisyjna pojedynczych fotonów (SPECT) i pozytonowa tomografia emisyjna (PET). Od ponad 40 lat medycyna nuklearna znajduje zastosowanie w kardiologii, szczególnie w diagnostyce choroby wieńcowej. W artykule omówiono najpowszechniej używane radioznaczniki, metody kardiologii nuklearnej i ich szczegółowe zastosowania.

Pobrania

Dane pobrania nie są jeszcze dostepne

##plugins.themes.bootstrap3.article.details##

Jak cytować
Różańska , M., Możeńska , O., Budlewski , T., & Kosior , D. A. (2017). Metody medycyny nuklearnej w nieinwazyjnej diagnostyce kardiologicznej. Kardiologia W Praktyce, 11(3), 29-36. Pobrano z https://journalsmededu.pl/index.php/kwp/article/view/1246
Dział
Artykuły

Bibliografia

1. Ustawa z dnia 29 listopada 2000 r. Prawo atomowe. Dz.U. 2001 nr 3 poz. 18 [online: http://isap.sejm.gov.pl/DetailsServlet?id=WDU20010030018].
2. Strauss H.W., Zaret B.L., Martin N.D. et al.: Noninvasive evaluation of regional myocardial perfusion with potassium 43. Technique in patients with exercise- induced transient myocardial ischemia. Radiology 1973; 108(1): 85-90.
3. Hesse B., Lindhardt T.B., Acampa W. et al.: EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur. J. Nucl. Med. Mol. Imaging 2008; 35(4): 851-885.
4. Schelbert H.R., Verba J.W., Johnson A.D. et al.: Nontraumatic determination of left ventricular ejection fraction by radionuclide angiocardiography. Circulation 1975; 51(5): 902-909.
5. Wackers F.J., Berger H.J., Johnstone D.E. et al.: Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: validation of the technique and assessment of variability. Am. J. Cardiol. 1979; 43(6): 1159-1166.
6. Hegge F.N., Hamilton G.W., Larson S.M. et al.: Cardiac chamber imaging: a comparison of red blood cells labeled with Tc-99m in vitro and in vivo. J. Nucl. Med. 1978; 19(2): 129-134.
7. Maurea S., Cuocolo A., Soricelli A. et al.: Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J. Nucl. Med. 1995; 36(11): 1945-1952.
8. Zaret B.L., Strauss H.W., Martin N.D. et al.: Noninvasive regional myocardial perfusion with radioactive potassium. Study of patients at rest, with exercise and during angina pectoris. N. Engl. J. Med. 1973; 288(16): 809-812.
9. Nielsen A.P., Morris K.G., Murdock R. et al.: Linear relationship between the distribution of thallium-201 and blood flow in ischemic and nonischemic myocardium during exercise. Circulation 1980; 61(4): 797-801.
10. Grunwald A.M., Watson D.D., Holzgrefe H.H. Jr et al.: Myocardial thallium-201 kinetics in normal and ischemic myocardium. Circulation 1981; 64(3): 610-618.
11. Sogbein O.O., Pelletier-Galarneau M., Schindler T.H. et al.: New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease. Biomed. Res. Int. 2014; 2014: 942960.
12. Pohost G.M., Zir L.M., Moore R.H. et al.: Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation 1977; 55(2): 294-302.
13. Cerqueira M.D., Allman K.C., Ficaro E.P. et al.: Recommendations for reducing radiation exposure in myocardial perfusion imaging. J. Nucl. Cardiol. 2010; 17(4): 709-718.
14. Husain S.S.: Myocardial perfusion imaging protocols: is there an ideal protocol? J. Nucl. Med. Technol. 2007; 35(1): 3-9.
15. Gibbons R.J., Balady G.J., Beasley J.W. et al.: ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J. Am. Coll. Cardiol. 1997; 30(1): 260-311.
16. Wilson R.F., Wyche K., Christensen B.V. et al.: Effects of adenosine on human coronary arterial circulation. Circulation 1990; 82(5): 1595-1606.
17. Thomas G.S., Miyamoto M.I.: Should simultaneous exercise become the standard for adenosine myocardial perfusion imaging? Am. J. Cardiol. 2004; 94(2A): 3D-10D; discussion 10D-11D.
18. Johnston D.L., Scanlon P.D., Hodge D.O. et al.: Pulmonary function monitoring during adenosine myocardial perfusion scintigraphy in patients with chronic obstructive pulmonary disease. Mayo Clin. Proc. 1999; 74(4): 339-346.
19. DePuey E.G., Rozanski A.: Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J. Nucl. Med. 1995; 36(6): 952-955.
20. Verberne H.J., Acampa W., Anagnostopoulos C. et al.: EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur. J. Nucl. Med. Mol. Imaging 2015; 42(12): 1929-1940.
21. Machac J.: Cardiac positron emission tomography imaging. Semin. Nucl. Med. 2005; 35(1): 17-36.
22. Schlyer D.J.: PET tracers and radiochemistry. Ann. Acad. Med. Singapore 2004; 33(2): 146-154.
23. Dilsizian V., Bacharach S.L., Beanlands R.S. et al.: ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J. Nucl. Cardiol. 2016; 23(5): 1187-1226.
24. Saby L., Laas O., Habib G. et al.: Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J. Am. Coll. Cardiol. 2013; 61(23): 2374-2382.
25. Scholtens A.M., Hein J. Verberne et al.: Additional Heparin Pre-administration Improves Cardiac Glucose Metabolism suppression over low-carbohydrate diet alone in 18F-FDG PET Imaging. J. Nucl. Med. 2016; 57(4): 568-573.
26. Ozcan C., Asmar A., Gill S. et al.: The value of FDG-PET/CT in the diagnostic work-up of extra cardiac infectious manifestations in infectious endocarditis. Int. J. Cardiovasc. Imaging 2013; 29(7): 1629-1637.
27. Graziosi M., Nanni C., Lorenzini M. et al.: Role of (1)(8)F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective study. Eur. J. Nucl. Med. Mol. Imaging 2014; 41(8): 1617-1623.
28. Erba P.A., Sollini M., Conti U. et al.: Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections. JACC Cardiovasc. Imaging 2013; 6(10): 1075-1086.